Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 75.41%294.03M | 69.38%417.31M | 61.65%167.62M | 54.99%246.37M | 90.15%103.7M | 183.11%158.96M | 162.15%54.54M | 328.73%56.15M | 965.73%20.8M | 6,792.63%13.1M |
| Operating income | 75.41%294.03M | 69.38%417.31M | 61.65%167.62M | 54.99%246.37M | 90.15%103.7M | 183.11%158.96M | 162.15%54.54M | 328.73%56.15M | 965.73%20.8M | 6,792.63%13.1M |
| Cost of sales | -175.33%-188.39M | -88.47%-192.24M | -66.94%-68.42M | -82.01%-102M | -102.59%-40.99M | -191.71%-56.04M | -295.45%-20.23M | -1,014.33%-19.21M | -23,154.55%-5.12M | -17,140.00%-1.72M |
| Operating expenses | -175.33%-188.39M | -88.47%-192.24M | -66.94%-68.42M | -82.01%-102M | -102.59%-40.99M | -191.71%-56.04M | -295.45%-20.23M | -1,014.33%-19.21M | -23,154.55%-5.12M | -17,140.00%-1.72M |
| Gross profit | 6.50%105.65M | 55.90%225.07M | 58.19%99.2M | 40.27%144.37M | 82.81%62.71M | 178.64%102.92M | 118.68%34.3M | 224.79%36.94M | 712.80%15.69M | 6,217.78%11.37M |
| Selling expenses | -6.45%-117M | -0.64%-227.7M | 4.14%-109.91M | -23.61%-226.25M | -45.70%-114.66M | -43.39%-183.04M | -74.45%-78.7M | -151.63%-127.65M | -174.63%-45.11M | -1,946.35%-50.73M |
| Administrative expenses | 7.15%-84.57M | 3.53%-189.21M | 8.51%-91.09M | -2.83%-196.14M | -32.05%-99.56M | -51.20%-190.75M | -29.87%-75.4M | 45.81%-126.16M | 61.47%-58.06M | -307.12%-232.81M |
| Research and development expenses | 33.59%-38.99M | 7.94%-113.94M | 19.68%-58.71M | 32.85%-123.77M | 25.75%-73.09M | -9.02%-184.31M | -6.72%-98.44M | 5.85%-169.06M | -77.02%-92.24M | -80.52%-179.55M |
| Impairment and provision | 148.97%95K | -86.53%-651K | 27.61%-194K | 48.90%-349K | 5.30%-268K | ---683K | ---283K | ---- | ---- | ---- |
| -Other impairment is provision | 148.97%95K | -86.53%-651K | 27.61%-194K | 48.90%-349K | 5.30%-268K | ---683K | ---283K | ---- | ---- | ---- |
| Special items of operating profit | -68.40%3.62M | 72.29%41.34M | -33.62%11.45M | -56.71%23.99M | -36.56%17.25M | -60.36%55.43M | -78.04%27.19M | 107.71%139.83M | 108.12%123.8M | -55.43%-1.81B |
| Operating profit | 12.09%-131.2M | 29.90%-265.09M | 28.12%-149.25M | 5.56%-378.16M | -8.52%-207.62M | -62.72%-400.44M | -242.12%-191.33M | 89.13%-246.09M | 96.79%-55.92M | -70.87%-2.26B |
| Financing cost | 54.90%-824K | -63.25%-2.16M | -185.92%-1.83M | 26.10%-1.33M | 34.86%-639K | -216.23%-1.79M | -176.34%-981K | -861.02%-567K | -1,443.48%-355K | 6.35%-59K |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---13.33M | ---13.33M | ---- |
| Earning before tax | 12.61%-132.03M | 29.57%-267.26M | 27.46%-151.08M | 5.66%-379.48M | -8.30%-208.26M | -54.71%-402.23M | -176.27%-192.31M | 88.52%-259.99M | 96.00%-69.61M | -70.87%-2.26B |
| Tax | -10.19%-292K | -231.27%-1.02M | -90.65%-265K | 25.85%-307K | 61.60%-139K | ---414K | ---362K | ---- | ---- | ---- |
| After-tax profit from continuing operations | 12.57%-132.32M | 29.36%-268.27M | 27.38%-151.34M | 5.68%-379.79M | -8.17%-208.4M | -54.87%-402.64M | -176.79%-192.67M | 88.52%-259.99M | 96.00%-69.61M | -70.87%-2.26B |
| Earning after tax | 12.57%-132.32M | 29.36%-268.27M | 27.38%-151.34M | 5.68%-379.79M | -8.17%-208.4M | -54.87%-402.64M | -176.79%-192.67M | 88.52%-259.99M | 96.00%-69.61M | -70.87%-2.26B |
| Profit attributable to shareholders | 12.57%-132.32M | 29.36%-268.27M | 27.38%-151.34M | 5.68%-379.79M | -8.17%-208.4M | -54.87%-402.64M | -176.79%-192.67M | 88.52%-259.99M | 96.00%-69.61M | -72.59%-2.26B |
| Basic earnings per share | 26.09%-0.17 | 33.90%-0.39 | 28.13%-0.23 | 7.81%-0.59 | -3.23%-0.32 | -48.84%-0.64 | -158.33%-0.31 | 93.86%-0.43 | 99.56%-0.12 | 78.13%-7 |
| Diluted earnings per share | 26.09%-0.17 | 33.90%-0.39 | 28.13%-0.23 | 7.81%-0.59 | -3.23%-0.32 | -48.84%-0.64 | -158.33%-0.31 | 93.86%-0.43 | 99.56%-0.12 | 78.13%-7 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.